FindTrial
Sign In

Role of individualized homoeopathic medicine in management of benign prostatic hyperplasia

To study the role of individualized homoeopathic medicines in managing benign prostatic hyperplasia by using ipss score - a prospective interventional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085703
Enrollment
46
Registered
2025-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: Individualized Homoeopathic Medicines: Individualized Homoeopathic Medicines will be prescribed in selective potency as in required repetition for 15 days or when it is required Control

Sponsors

Dr. Bina Sonagara
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient with dysuria, urgency and frequent urination with evidence of prostatic hyperplasia confirmed by ultrasonographic findings 2.Age 40 to 80 3.Patient who are willing to give consent. 4.All socioeconomic status

Exclusion criteria

Exclusion criteria: 1.Patients with frequent urination or retention of urine due to systemic or neurological disorder. 2.Prostatitis 3.Frequent urination due to urinary tract infection 4.Urethral stricture 5.Prostate and urethral calculi 6.Patient with bladder disorder 7.Ca - prostate

Design outcomes

Primary

MeasureTime frame
1.To study the role of individualized homoeopathic medicines in cases of Benign Prostatic Hyperplasia by using IPSS score.Timepoint: 4 MONTHS—

Secondary

MeasureTime frame
1.To assess the severity & outcome of patients before & after treatment in cases of BPH by using IPSS score.Timepoint: 4 MONTHS—

Countries

India

Contacts

Public ContactDr Kaushik Pancholi

Jawaharlal Nehru Homoeopathic Medical College.Parul University

dr.kaushikpancholi@gmail.com9898451496

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026